Centers | ||
|
|
|
Chemical Genomics Facility at Purdue Institute for Drug Discovery | Experimental Pharmacology Laboratory | BLAVATNIK CENTER for Drug Discovery |
The Chemical Genomics Facility is a core facility at Purdue Institute for Drug Discovery that provides expertise and resources needed in the early stage of drug discovery. The services include small molecule libraries, access to automated equipment... Read more |
The University of Cyprus Experimental Pharmacology Laboratory is a molecular and behavioural pharmacology laboratory based in the Medical School of the University of Cyprus. Read moreOur research revolves around novel drug discovery and drug repurposing... |
The BLAVATNIK CENTER for Drug Discovery (BCDD) is a fully integrated center for translational research, based at Tel Aviv University, that comprises medicinal chemistry, biological target identification and computer-assisted drug design units under... Read more |
Partnerships |
Events |
Jobs |
Novartis and University of Pennsylvania form Alliance in Oncology AreaUniversity of Pennsylvania and Novartis have joined hands together to start a new Center for Advanced Cellular Therapies (CACT). The new center will be based out of University of Pennsylvania campus and will be responsible to develop T Cell... View all Research Collaboration and license agreementThe Drug Discovery Unit announces a partnership with Takeda, Japan’s largest pharmaceutical company, to develop possible new therapeutic treatments for tau pathology, an underlying feature in several forms of neurodegeneration, including... View all Johns Hopkins BSi Licenses GCPII Assets from EisaiJohns Hopkins Brain Science Institute ("BSi") has taken a non-exclusive license from Eisai to develop new compounds related to Glutamate Carboxypeptidase II (GCP-II) technology. The new compounds developed under this license will be targeted... View all |
No EVENTS for listing |
No Job Posts |
